摘要
目的 探讨医用臭氧在慢性乙肝患者治疗过程中抗纤维化及抗病毒作用的效果.方法 以我院2011年8月至2013年8月间收治的100例慢性乙肝患者为研究对象,随机分为观察组与对照组,所有患者均进行常规治疗,观察组患者在此基础上增加医用臭氧治疗,比较两组患者临床治疗效果、肝纤维化指标及抗病毒能力之间的差异.结果 观察组患者临床治疗效果和抗病毒能力高于对照组,肝纤维化水平低于对照组,其差异有统计学意义(P<0.05).结论 医用臭氧可以在乙肝患者的治疗中起到积极作用,其可降低患者肝纤维化水平,提高患者机体抗病毒能力,增强临床治疗效果.
Objective To investigate the effects of medical ozone in the treatment of chronic hepatitis b for anti-fibrosis and antiviral.Methods One hundred patients with chronic hepatitis b were divided into the observation group and control group.The conventional treatment plan was used in all the patients and the medical ozone was additionally used in the observation group.The clinical effect,the degree of anti-fibrosis and antiviral were compared between the two groups.Results The clinical effect and the degree of antiviral of the observation group were higher than those of the control group,and the fibrosis degree of the observation group was lower than that of the control group (P < 0.05).Conclusion Medical ozone can get a positive satisfaction effect in the treatment of chronic hepatitis b,improve clinical curative effects,reduce the degree of patients' anti-fibrosis and increase their antiviral capability.
出处
《国际医药卫生导报》
2014年第3期297-300,共4页
International Medicine and Health Guidance News
基金
广东省医学科研基金立项课题(A2013786)
关键词
医用臭氧
乙肝
纤维化
Medical ozone
Chronic hepatitis b
Fibrosis